CANNASIGNAL™
LIVE DATA
🔍
SIGNAL
HEMP BAN: Federal intoxicating-hemp ban takes effect Dec 11, 2026 — consumer migration to licensed markets expectedFEDERAL: Schedule III rescheduling in progress — 280E relief expected late 2026FEDERAL RISK INDEX: 37/100 (LOW) — rescheduling momentum growingVA: Adult-use retail launches Jul 1, 2027 — license applications open Feb 1, 2027IL: SB 3222 omnibus signed — possession limits doubled, intoxicating hemp moves to dispensaries Nov 12MI: 24% wholesale tax challenged in court — repeal bill SB 810 pending in committeeCA: Cannabis excise tax locked at 15% through July 2028 per AB 564NJ: Cannabis consumption lounges now open in Atlantic City, Newark, MerchantvilleMN: Omnibus Cannabis Act signed — hemp-to-cannabis license bridge ahead of federal banOK: Governor pushes to eliminate medical program — bipartisan opposition buildingHEMP BAN: Federal intoxicating-hemp ban takes effect Dec 11, 2026 — consumer migration to licensed markets expectedFEDERAL: Schedule III rescheduling in progress — 280E relief expected late 2026FEDERAL RISK INDEX: 37/100 (LOW) — rescheduling momentum growingVA: Adult-use retail launches Jul 1, 2027 — license applications open Feb 1, 2027IL: SB 3222 omnibus signed — possession limits doubled, intoxicating hemp moves to dispensaries Nov 12MI: 24% wholesale tax challenged in court — repeal bill SB 810 pending in committeeCA: Cannabis excise tax locked at 15% through July 2028 per AB 564NJ: Cannabis consumption lounges now open in Atlantic City, Newark, MerchantvilleMN: Omnibus Cannabis Act signed — hemp-to-cannabis license bridge ahead of federal banOK: Governor pushes to eliminate medical program — bipartisan opposition building
WV HB4640Introducedas of 2026-01-21

Relating to drugs and adding a provision relating to the scheduling of crystalline polymorph psilocybin approved by the Food and Drug Administration

Plain-English summary

What happened: A West Virginia bill adding FDA-approved crystalline polymorph psilocybin to the state's drug scheduling framework is on its first reading in the House.

Why it matters: Scheduling FDA-approved crystalline polymorph psilocybin would establish a legal framework governing how this compound may be dispensed or accessed in West Virginia.

Affects: patients

LATEST ACTION: On 1st reading, House Calendar
READ THE FULL BILL TEXT →
Follow West Virginia cannabis bills for free. One plain-English email a week with every bill that moved, including this one.
Get the free digest
More West Virginia cannabis bills
SB906Permitting lawful prescription of crystalline polymorph psilocybin under FDA recommendationsPassedHB5074Relating to changing the allocation of proceeds in the Medical Cannabis Program Fund.VetoedHB5260Relating generally to medical cannabisIn CommitteeHB5658Compassionate Access to Medical Cannabis Act or Ryan’s Law.IntroducedHB5588Establish a regulated framework for the medical use of psilocybin to treat post-traumatic stress disorder (PTSD)IntroducedSB892Modifying allowable forms of medical cannabis to include edible formIntroducedSB809Rescheduling cannabis from Schedule 1 to Schedule 3IntroducedSB808Regulating consumable hemp productsIntroduced
ALL WEST VIRGINIACANNABIS LAWS & BILLS →

Legislative data via LegiScan, licensed under CC BY 4.0. Summaries and categorization by CannaSignal. Regulatory information, not legal advice.